Literature DB >> 33164060

Pembrolizumab-related sclerosing cholangitis manifested by a pruned-tree appearance of the bile ducts.

Masaki Takinami1, Akira Ono1, Michihisa Moriguchi2,3, Toshiaki Takahashi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33164060     DOI： 10.1093/jjco/hyaa201

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN： 0368-2811            Impact factor:   3.019


× No keyword cloud information.
  2 in total

1.  Imaging features of toxicities associated with immune checkpoint inhibitors.

Authors:  Babina Gosangi; Lacey McIntosh; Abhishek Keraliya; David Victor Kumar Irugu; Akshay Baheti; Ashish Khandelwal; Richard Thomas; Marta Braschi-Amirfarzan
Journal:  Eur J Radiol Open       Date:  2022-08-08

2.  Comparison of clinical features between immune-related sclerosing cholangitis and hepatitis.

Authors:  Masaki Takinami; Akira Ono; Takanori Kawabata; Nobuaki Mamesaya; Haruki Kobayashi; Shota Omori; Kazushige Wakuda; Hirotsugu Kenmotsu; Tateaki Naito; Haruyasu Murakami; Masahiro Endo; Yoshio Kiyohara; Hirofumi Yasui; Masashi Niwakawa; Toshiaki Takahashi
Journal:  Invest New Drugs       Date:  2021-05-28       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.